"The industry is moving beyond conventional point based traditional inspection methods, which are typically slow, laborious and require shutdown periods, to faster advanced technology and data-driven approaches that reduce non-productive time of the assets."
"We are in a dysfunctional supply-demand balance and the price will bounce back, probably around 2028; the year when Atlantic Lithium should start production."
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.